SANOFI
EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.
SANOFI has 81 disclosed EU lobbying meetings from 2020-04-06 to 2026-10-14: 62 with the European Commission and 19 with Members of the European Parliament. Source: EU Transparency Register no. 61291462764-77, Commission disclosures and MEP declarations.
Lobbying profile
as declared 2026-03-18- Category
- Companies & groups
- Legal status
- Public limited company
- Declared lobbying cost
- €1,500,000
- Lobbying FTEs
- 2.5
- Members
- 2
Files it’s lobbying on
The org's disclosed policy areas, ranked by number of meetings.
Declared fields of interest
Business and industry · Climate action · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Employment and social affairs · Environment · External relations · Humanitarian aid and civil protection · Institutional affairs
At a glance
The officials and MEPs most often met, by disclosed-meeting count.
- Olivér Várhelyi4
- Stéphane Séjourné4
- Eszter Batta4
- Thierry Breton3
- Arthur Corbin2
Disclosed meetings
Newest first, showing the most recent 60 of 81. EC = European Commission, EP = Member of the European Parliament.
- 2026-10-14ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiEU-Mexico health cooperationsource ↗
- 2026-10-14ECElena Martines · Cabinet of Commissioner Ekaterina ZaharievaEurope’s competitive advantagesource ↗
- 2026-10-14ECEkaterina Zaharieva · Cabinet of Commissioner Ekaterina ZaharievaEurope’s competitive advantagesource ↗
- 2026-10-14ECIvan Dimov · Cabinet of Commissioner Ekaterina ZaharievaEurope’s competitive advantagesource ↗
- 2026-09-10ECStéphane Séjourné · Cabinet of Executive Vice-President Stéphane SéjournéExchange on the issues of competitiveness of European industrysource ↗
- 2026-09-10ECAleksandra Kordecka · Cabinet of Executive Vice-President Stéphane SéjournéExchange on the issues of competitiveness of European industrysource ↗
- 2026-07-09ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiBiotech Actsource ↗
- 2026-07-09ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiBiotech Actsource ↗
- 2026-07-08ECHeinz Jansen · Principal AdviserCompetitiveness Coordination Tool – exchanges with the industrysource ↗
- 2026-07-03ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiLife Sciences Roundtablesource ↗
- 2026-06-16ECArthur Corbin · Cabinet of Executive Vice-President Stéphane SéjournéIndustry Trade Automotivesource ↗
- 2026-05-28ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiChallenges and priorities for health and life sciencessource ↗
- 2026-05-28ECFlavio Facioni · Cabinet of Commissioner Olivér VárhelyiChallenges and priorities for health and life sciencessource ↗
- 2026-05-12ECMartina Lodrant · Cabinet of President Ursula von der LeyenPresenting Sanofi’s priority topic ahead of the G7 Summit in Eviansource ↗
- Biotech Actsource ↗
- Biotech Act Isource ↗
- 2026-04-09ECMaria Pilar Aguar Fernandez · DirectorSanofi’s research and development (R&D) strategy in the European context.source ↗
- Biotech Actsource ↗
- Biotech Actsource ↗
- Health policysource ↗
- 2026-02-03ECCarmen Laplaza Santos · Head of UnitExchange of views on the competitiveness of the European pharmaceutical sector.source ↗
- 2026-01-28ECVita Jukne · Cabinet of Commissioner Jessika RoswallImplication of REACH revision and the upcoming Per- and Polyfluoroalkyl Substances (PFAS)source ↗
- Site visitsource ↗
- Cardiovascular Healthsource ↗
- 2025-12-05ECStéphane Séjourné · Cabinet of Executive Vice-President Stéphane SéjournéIndustrie pharmaceutique, innovation et souveraineté sanitaire européenne.source ↗
- 2025-12-05ECSacha Halphen · Cabinet of Executive Vice-President Stéphane SéjournéIndustrie pharmaceutique, innovation et souveraineté sanitaire européenne.source ↗
- 2025-10-28ECDorota Denning · Cabinet of Commissioner Valdis DombrovskisRoundtable on Simplification for Pharmaceutical Innovationsource ↗
- Competiveness in the Healthcare sectorsource ↗
- 2025-09-10ECCecile Billaux · Head of UnitOverview of Sanofi’s actions in global health and on local manufacturing in Africasource ↗
- 2025-09-05ECStéphane Séjourné · Cabinet of Executive Vice-President Stéphane Séjourné- Compétitivité des entreprises - Marché intérieur - Protection de la souveraineté et du pouvoir d’achat - Relation US/EUsource ↗
- 2025-09-04ECRainer Becker · DirectorExchange of views on multinational clinical trials in the context of the upcoming Biotech Actsource ↗
- 2025-09-04ECLucilla Sioli · DirectorVirtual Human Twinssource ↗
- 2025-09-04ECSaila Rinne · Head of UnitVirtual Human Twinssource ↗
- 2025-07-29ECFlorika Fink-Hooijer · Director-GeneralHealth security and innovation across Europe, SANOFI’s relevant activitiessource ↗
- 2025-07-15ECMarco Marsella · DirectorThe Digital Human. This flagship program leverages AI-driven avatars and advanced health data solutions.source ↗
- 2025-07-08ECVilija Sysaite · Cabinet of Executive Vice-President Stéphane SéjournéChallenges of Sanofi in Europe and opportunities to enhance investment and innovation in the pharmaceutical sectorsource ↗
- 2025-06-26ECStéphane Séjourné · Cabinet of Executive Vice-President Stéphane SéjournéCompétitivité; relations USE-UE, CSRD/CS3D, Simplificationsource ↗
- 2025-06-26ECArthur Corbin · Cabinet of Executive Vice-President Stéphane SéjournéCompétitivité; relations USE-UE, CSRD/CS3D, Simplificationsource ↗
- 2025-06-26ECSacha Halphen · Cabinet of Executive Vice-President Stéphane SéjournéCompétitivité; relations USE-UE, CSRD/CS3D, Simplificationsource ↗
- 2025-06-05ECKerstin Jorna · Director-GeneralChallenges for the EU pharmaceutical industrysource ↗
- 2025-06-03ECGabriela Tschirkova · Cabinet of Commissioner Valdis DombrovskisSimplificationsource ↗
- 2025-06-03ECMichael Hager · Cabinet of Commissioner Valdis DombrovskisCompetitiveness of the pharmaceutical sectorsource ↗
- 2025-05-28ECAnn-Sofie Ronnlund · Cabinet of Commissioner Ekaterina ZaharievaLife sciencessource ↗
- 2025-05-13ECEgelyn Braun · Cabinet of Commissioner Michael McGrathExchange of views on competitiveness, simplification and collective redresssource ↗
- 2025-04-04ECTobias Wiesenthal · Head of UnitScientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-04-04ECMaurice Whelan · Head of UnitScientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-04-02ECNicolo Brignoli · Cabinet of Commissioner Valdis DombrovskisCompetitivenesssource ↗
- 2025-03-28ECLucie Šestáková · Cabinet of Commissioner Jozef SíkelaGlobal Gatewaysource ↗
- 2025-03-28ECNatividad Lorenzo · Cabinet of Commissioner Jozef SíkelaGlobal Gatewaysource ↗
- Healthsource ↗
- 2025-03-19ECFelice Zaccheo · Head of UnitTo discuss Sanofi’s involvement in LAC and opportunities for actionable cooperations under the GGIA to contribute to health self-sufficiency in LAC.source ↗
- 2025-03-12ECOlivier Girard · Head of UnitDiscussion on Joint procurement to improve availability of antibiotics and avoid shortagessource ↗
- Health policysource ↗
- Introductory Meetingsource ↗
- Pharmaceutical Industrysource ↗
- 2025-01-27ECMaurice Whelan · Head of UnitExploit interest in a scientific roundtable between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- 2025-01-27ECTobias Wiesenthal · Head of UnitExploit interest in a scientific roundtable between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovationsource ↗
- European healthcaresource ↗
- European health policysource ↗
- Pharmaceutical sectorsource ↗
Frequently asked
How many EU lobbying meetings has SANOFI disclosed?
SANOFI (EU Transparency Register no. 61291462764-77) appears in 81 disclosed meetings with EU officials and MEPs between 2020-04-06 and 2026-10-14: 62 with the European Commission and 19 with Members of the European Parliament.
What does SANOFI lobby on?
SANOFI's disclosed EU meetings most often concern Health, Technology, Industry, Trade. Every meeting and its topic is listed with its official source on this page.
Who does SANOFI meet in Brussels?
Across its disclosed meetings, SANOFI has met Commission officials including Olivér Várhelyi, Stéphane Séjourné, Eszter Batta, and MEPs including SOKOL Tomislav, KULJA András Tivadar, ANDRIUKAITIS Vytenis Povilas. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Related on the graph
The same footprint, mapped onto the topics and files it touches.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.
See your company’s overlap with SANOFI — and the rest of the corpus.
Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.